Showing items 1931-1980 of 2489 (50 Page(s) Totally)
<< < 34 35 36 37 38 39 40 41 42 43 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-11-02T02:04:40Z |
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
|
MING-SHIANG WU; Lee Y.-C.; Chen C.-C.; Lin J.-T.; Liang J.-T.; Shun C.-T.; Chiu H.-M.; Chang L.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:38Z |
Association of esophageal inflammation, obesity and gastroesophageal reflux disease: From FDG PET/CT perspective
|
Yang W.-S.; MING-SHIANG WU; Lin J.-T.; Wang H.-P.; Tu C.-H.; Chiu H.-M.; Wang S.-Y.; Lee Y.-C.; Wu Y.-W.; Tseng P.-H. |
| 臺大學術典藏 |
2020-11-02T02:04:35Z |
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan
|
Sheng W.-H.; Liou J.-M.; Wang H.-P.; MING-SHIANG WU; Lin J.-T.; Chang S.-C.; Cheng A. |
| 臺大學術典藏 |
2020-11-02T02:04:34Z |
Blood glucose concentration and risk of pancreatic cancer: Systematic review and dose-response meta-analysis
|
Chien K.-L.; Wang H.-P.; Lin J.-T.; Liao W.-C.; Tu Y.-K.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:34Z |
Evaluation of the effect of cumulative operator experience on hepatocellular carcinoma recurrence after primary treatment with radiofrequency ablation
|
Lee T.-Y.; Lin J.-T.; Ho H.J.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-02T02:04:33Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Lee Y.-C.; Wang W.-L.; Lee C.-T.; Tai C.-M.; MING-SHIANG WU; Bair M.-J.; Lin J.-T.; Sheu B.-S.; Wang H.-P.; Chang C.-C.; Yang T.-H.; Wu C.-Y.; Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; Wang Y.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:32Z |
Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance
|
Lin J.-T.; Sheu B.-S.; Chiu C.-T.; Lee Y.-C.; Chang C.-Y.; Wu D.-C.; Liou J.-M.; MING-SHIANG WU; Chang W.-L.; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-02T02:04:29Z |
Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection
|
Chen M.-J.; Liou J.-M.; Chen C.-C.; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:29Z |
Prevention of gastric cancer by helicobacter pylori eradication: Current evidence and future prospects
|
Liou J.-M.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:27Z |
Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation
|
Lee T.-Y.; Lin J.-T.; Zeng Y.-S.; Chen Y.-J.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Helicobacter Consortium; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU; the Taiwan Gastrointestinal Disease; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen�VNegative Patients
|
Lin J.-T.; Wu C.-Y.; Hung H.-W.; Fang Y.-J.; Chen C.-C.; Chiang M.-F.; Wang C.-S.; Yang T.-H.; Wang W.-L.; Kao J.-H.; MING-SHIANG WU; Chang C.-Y.; Hsu Y.-C.; Mo L.-R. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection
|
Chen P.-Y.; MING-SHIANG WU; Chen C.-Y.; Bair M.-J.; Chou C.-K.; Lin J.-T.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-02T02:04:25Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium; Chang C.-C.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Hsu Y.-C.; Chen C.-C.; Tseng C.-H.; Chen M.-J.; Lee Y.-C.; Chang C.-Y.; Bair M.-J.; Chen C.-C.; Fang Y.-J.; Liou J.-M. |
| 臺大學術典藏 |
2020-11-02T02:04:24Z |
Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make?the?Switch in Clinical?Practice?
|
Liou J.-M.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:23Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
MING-SHIANG WU; Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:22Z |
Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale
|
Wu D.-C.; Liou J.-M.; Wu C.-Y.; Cheng H.-C.; Lee Y.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T.; Lo J.-C.; Chiu C.-T.; MING-SHIANG WU; Sheu B.-S. |
| 臺大學術典藏 |
2020-11-02T02:04:21Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Lin J.-T.; Wu C.-Y.; Lin C.-W.; Tai C.-M.; Chen C.-C.; Tseng C.-H.; Kao J.-H.; Yang T.-H.; MING-SHIANG WU; Chang C.-Y.; Mo L.-R.; Hsu Y.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:20Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; MING-SHIANG WU; Chen C.-C.; Chen C.-C.; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-02T02:04:20Z |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis
|
Microbiota; for the, Asian Pacific Alliance on Helicobacter; MING-SHIANG WU; Tu Y.-K.; Yamaoka Y.; Lin J.-T.; Lu H.; Das R.; Goh K.L.; Leow A.H.R.; Wu J.-Y.; El-Omar E.M.; Liou J.-M.; Kuo Y.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:19Z |
Nutrition therapy in esophageal cancer�XConsensus statement of the Gastroenterological Society of Taiwan
|
Chu C.-H.; MING-SHIANG WU; Lin J.-T.; Sheu B.-S.; Chang W.-K.; Huang W.-C.; Yang C.-L.; Chang Y.-F.; Wang T.-E.; Chen Y.-J.; Wu I.-C.; Chen M.-J. |
| 臺大學術典藏 |
2020-11-02T02:04:19Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; MING-SHIANG WU; Bair M.-J.; Lee Y.-C.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G. |
| 臺大學術典藏 |
2020-11-02T02:04:18Z |
Prior gastroscopy and mortality in patients with gastric cancer: a matched retrospective cohort study
|
Leung W.K.; Ho H.J.; Lin J.-T.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-02T02:04:18Z |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis
|
Wu C.-Y.; Liou J.-M.; MING-SHIANG WU; Lin J.-T.; Zou B.; Ho H.J.; Shiu S.-I.; Yeo Y.H. |
| 臺大學術典藏 |
2020-11-02T02:04:16Z |
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir
|
Hsu Y.-C.; Ho H.-J.; Lee T.-Y.; Huang Y.-T.; MING-SHIANG WU; Lin J.-T.; Wu C.-Y.; El-Serag H.B. |
| 臺大學術典藏 |
2020-11-02T02:04:13Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; MING-SHIANG WU; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; MING-SHIANG WU; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S. |
| 臺大學術典藏 |
2020-11-02T02:04:12Z |
Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B
|
Tseng C.-H.; Hsu Y.-C.; Chang C.-Y.; Tseng T.-C.; MING-SHIANG WU; Lin J.-T.; Kao J.-H. |
| 臺大學術典藏 |
2020-11-02T02:04:10Z |
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
|
Chang C.-Y.; Lin J.-T.; Tanaka Y.; Wu C.-Y.; Tseng C.-H.; Tai C.-M.; Hsu Y.-C.; Nguyen M.H.; Mo L.-R.; MING-SHIANG WU; Yang T.-H.; Chen C.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:09Z |
Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication
|
Helicobacter Consortium; Taiwan Gastrointestinal Disease; Wu C.-Y.; Liou J.-M.; MING-SHIANG WU; Lin J.-T.; Ho H.J.; Lee C.-C.; Hsu C.-C.; Yeo Y.H. |
| 臺大學術典藏 |
2020-11-02T02:04:07Z |
Corrigendum to ��Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B�� [J Hepatol 69 (2018) 278�V285](S0168827818301703)(10.1016/j.jhep.2018.02.032)
|
Hsu Y.-C.; Wu C.-Y.; Wong G.L.-H.; Lin J.-T.; MING-SHIANG WU; Lee T.-Y.; El-Serag H.B.; Huang Y.-T.; Wong V.W.-S.; Yip T.C.-F.; Ho H.J. |
| 臺大學術典藏 |
2020-11-02T02:04:06Z |
Association of Daily Aspirin Therapy with Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
|
Lee T.-Y.; Hsu Y.-C.; Tseng H.-C.; Yu S.-H.; Lin J.-T.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-02T02:04:06Z |
Serum pepsinogen as a predictor for gastric cancer death A 16-year community-based cohort study
|
Lin M.-W.; Chen T.H.-H.; Lee Y.-C.; Lin J.-T.; MING-SHIANG WU; Shun C.-T.; Chiu H.-M.; Chou C.-K.; Liu C.-Y.; Fann J.C.-Y.; Yen A.M.-F.; Chen S.L.-S.; Chiu S.Y.-H.; Chiang T.-H. |
| 臺大學術典藏 |
2020-11-02T02:04:03Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Helicobacter Consortium; Taiwan Gastrointestinal Disease; MING-SHIANG WU; El-Omar E.M.; Chuang E.Y.; Lu T.-P.; Lin J.-T.; Wu J.-Y.; Chen Y.-N.; Hsu W.-F.; Chen C.-Y.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Chen C.-C.; Liou J.-M.; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J. |
| 臺大學術典藏 |
2020-11-02T02:04:02Z |
Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands
|
Lin M.-W.; MING-SHIANG WU; Lin J.-T.; Chen H.-H.; Ushijima T.; Graham D.Y.; Lee Y.-C.; Chiu H.-M.; Chiang H.; Shun C.-T.; Liu C.-Y.; Chen S.L.-S.; Chiu S.Y.-H.; Chen Y.-N.; Chou Y.-H.; Shieh C.-F.; Chan C.-C.; Yamada H.; Chiang T.-H.; Maeda M. |
| 臺大學術典藏 |
2020-11-02T02:04:02Z |
Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: A long-term cohort study on Matsu Islands
|
Lee Y.-C.; Chen H.-H.; Graham D.Y.; Chan C.-C.; Lin J.-T.; MING-SHIANG WU; Lin M.-W.; Shun C.-T.; Chiang H.; Chiu H.-M.; Liu C.-Y.; Shieh C.-F.; Chuang S.-L.; Chen Y.-R.; Chiu S.Y.-H.; Fann J.C.-Y.; Yen A.M.-F.; Chen S.L.-S.; Chang W.-J.; Chiang T.-H. |
| 臺大學術典藏 |
2020-10-27T12:04:27Z |
The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer
|
Chiu H.-M; Tseng P.-H; Lo J.-L; Hwang T.-Z; Wang C.-C; Tseng C.-H; Tai C.-M; Wang W.-L;Wang C.-P;Wang H.-P;Lee C.-T;Chang C.-Y;Tai C.-M;Tseng C.-H;Hwang T.-Z;Wang C.-C;Lo J.-L;Tseng P.-H;Chiu H.-M;Lee J.-M;Ko J.-Y;Pei-Jen Lou;Wu M.-S;Lee Y.-C;Lin J.-T.; Wang W.-L; Wang C.-P; Wang H.-P; Lee C.-T; Chang C.-Y; Lee J.-M; Ko J.-Y; PEI-JEN LOU; Wu M.-S; Lee Y.-C; Lin J.-T. |
| 臺大學術典藏 |
2020-10-15T03:58:09Z |
Risk Factors for intestinal metaplasia in adult residents of Matzu: A cross-sectional study
|
CHIA-HSUIN CHANG; Wu M.-S.; Chang Y.-T.; Chang M.-C.; Shun C.-T.; Liu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2020-09-30T08:49:39Z |
Normal values and symptom correlation of a simplified oatmeal-based gastric emptying study in the Chinese population
|
Tseng P.-H.; YEN-WEN WU; Lee Y.-C.; Cheng M.-F.; Tzen K.-Y.; Wang H.-P.; Lin J.-T.; Hsieh S.-T.; Yang W.-S.; Wu M.-S. |
| 臺大學術典藏 |
2020-09-30T08:49:38Z |
Association of esophageal inflammation, obesity and gastroesophageal reflux disease: From FDG PET/CT perspective
|
YEN-WEN WU; Tseng P.-H.; Lee Y.-C.; Wang S.-Y.; Chiu H.-M.; Tu C.-H.; Wang H.-P.; Lin J.-T.; Wu M.-S.; Yang W.-S. |
| 臺大學術典藏 |
2020-09-30T03:23:22Z |
Amebic liver abscess with a hepatogastric fistula
|
Chang Y.-T.;Wu M.-S.;Chien-Ching Hung;Lin J.-T.; Chang Y.-T.; Wu M.-S.; CHIEN-CHING HUNG; Lin J.-T. |
| 臺大學術典藏 |
2020-09-30T03:23:18Z |
Low prevalence of Helicobacter pylori but high prevalence of cytomegalovirus-associated peptic ulcer disease in AIDS patients: Comparative study of symptomatic subjects evaluated by endoscopy and CD4 counts
|
Lin J.-T.; Chiu H.-M.;Wu M.-S.;Chien-Ching Hung;Shun C.-T.;Lin J.-T.; Chiu H.-M.; Wu M.-S.; CHIEN-CHING HUNG; Shun C.-T. |
| 臺大學術典藏 |
2020-09-29T01:48:33Z |
Hepatic lymphoma mimicking liver abscess: Report of a case and review of the literature
|
YEE-CHUN CHEN; Lin J.-T.; Yang P.-M.; Wu M.-S.; Su I.-J.; Wang T.-H. |
| 臺大學術典藏 |
2020-09-22T09:06:24Z |
Radiographic and computed tomographic findings of gastric mucosa- associated lymphoid tissue lymphomas
|
STEVEN SHINN-FORNG PENG; Tsang Y.-M.; Lin J.-T.; Wang H.-H.; Chiang I.-P.; Hsu J.C.-Y. |
| 臺大學術典藏 |
2020-09-22T08:51:57Z |
Radiographic and computed tomographic findings of gastric mucosa- associated lymphoid tissue lymphomas
|
Peng S.S.-F.; Tsang Y.-M.; Lin J.-T.; Wang H.-H.; Chiang I.-P.; Hsu J.C.-Y. |
| 臺大學術典藏 |
2020-08-05T02:46:37Z |
Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori
|
Yu S.?C.; Lee P.?H.; Chang K.?J.; Wei T.?C.; Chen K.?M.; Lee W.?C.; Wen-Jeng Lee;Lin J.?T.;Shun C.?T.;Lee W.?C.;Yu S.?C.;Lee P.?H.;Chang K.?J.;Wei T.?C.;Chen K.?M.; WEN-JENG LEE; Lin J.?T.; Shun C.?T. |
| 臺大學術典藏 |
2020-08-05T02:46:37Z |
Gastric cancer in Taiwan
|
Wu M.S.; Lin J.T.; WEN-JENG LEE; Yu S.C.; Wang T.H. |
| 臺大學術典藏 |
2020-08-05T02:46:36Z |
Microsatellite instability in gastric carcinoma with special references to histopathology and cancer stages
|
Lin J.-T.;Wu M.-S.;Shun C.-T.;Wen-Jeng Lee;Wang J.-T.;Wang T.-H.;Sheu J.-C.; Lin J.-T.; Wu M.-S.; Shun C.-T.; WEN-JENG LEE; Wang J.-T.; Wang T.-H.; Sheu J.-C. |
| 臺大學術典藏 |
2020-08-05T02:46:35Z |
Relationship of mucopolysaccharide change, Helicobacter pylori infection and expression of P-53 in gastric cancer
|
Chuang S.-M.; Lin J.-T.; Wu M.-S.; WEN-JENG LEE; Shun C.-T.; Shun C.-T.;Wu M.-S.;Wen-Jeng Lee;Lin J.-T.;Chuang S.-M. |
| 臺大學術典藏 |
2020-08-05T02:46:35Z |
Genetic alterations in gastric cancer: Relation to histological subtypes, tumor stage, and Helicobacter pylori infection
|
Wu M.-S.;Shun C.-T.;Wang H.-P.;Sheu J.-C.;Wen-Jeng Lee;Wang T.-H.;Lin J.- T.; Wu M.-S.; Shun C.-T.; Wang H.-P.; Sheu J.-C.; WEN-JENG LEE; Wang T.-H.; Lin J.- T. |
| 臺大學術典藏 |
2020-08-05T02:46:34Z |
Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of Intestinal metaplasia
|
Wu M.-S.; Shun C.-T.; Lee W.-C.; Chen C.-J.; Wang H.-P.; WEN-JENG LEE; Sheu J.-C.; Lin J.-T. |
Showing items 1931-1980 of 2489 (50 Page(s) Totally)
<< < 34 35 36 37 38 39 40 41 42 43 > >>
View [10|25|50] records per page
